These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9745447)

  • 1. Insulin-like growth factor binding protein-3: a novel biomarker for the assessment of the synthetic capacity of hepatocytes in liver cirrhosis.
    Shaarawy M; Fikry MA; Massoud BA; Lotfy S
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3316-9. PubMed ID: 9745447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum insulin like growth factor-1 (IGF-1) and insulin like growth factor binding protein-3 (IGFBP-3) levels in liver cirrhosis.
    Colakoğlu O; Taşkiran B; Colakoğlu G; Kizildağ S; Ari Ozcan F; Unsal B
    Turk J Gastroenterol; 2007 Dec; 18(4):245-9. PubMed ID: 18080921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor binding protein-3 in patients with liver cirrhosis.
    Sídlová K; Pechová M; Kotaska K; Průsa R
    Physiol Res; 2002; 51(6):587-90. PubMed ID: 12511182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ratio of insulin-like growth factor-I/insulin-like growth factor-binding protein-3 in sera of patients with hepatitis C virus-related chronic liver disease as a predictive marker of insulin resistance.
    Himoto T; Tani J; Miyoshi H; Yoneyama H; Mori H; Inukai M; Masugata H; Goda F; Senda S; Haba R; Masaki T
    Nutr Res; 2013 Jan; 33(1):27-33. PubMed ID: 23351407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentrations, release, and disposal of insulin-like growth factor (IGF)-binding proteins (IGFBP), IGF-I, and growth hormone in different vascular beds in patients with cirrhosis.
    Møller S; Juul A; Becker U; Flyvbjerg A; Skakkebaek NE; Henriksen JH
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1148-57. PubMed ID: 7536200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of insulin-like growth factor-I and insulin-like growth factor binding proteins during thioacetamide-induced liver cirrhosis in rats.
    Novosyadlyy R; Dargel R; Scharf JG
    Growth Horm IGF Res; 2005 Oct; 15(5):313-23. PubMed ID: 16098781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGF-I and IGFBP-3 serum levels in patients hospitalized for complications of liver cirrhosis.
    Ronsoni MF; Lazzarotto C; Fayad L; Silva MC; Nogueira CL; Bazzo ML; Narciso-Schiavon JL; Dantas-Corrêa EB; Schiavon Lde L
    Ann Hepatol; 2013; 12(3):456-63. PubMed ID: 23619263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of serum IGF-I, IGF-II and IGFBP-3 in liver cirrhosis.
    Wu YL; Ye J; Zhang S; Zhong J; Xi RP
    World J Gastroenterol; 2004 Sep; 10(18):2740-3. PubMed ID: 15309731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum IGF-1, IGF-2 and IGFBP-3 as parameters in the assessment of liver dysfunction in patients with hepatic cirrhosis and in the diagnosis of hepatocellular carcinoma.
    Rehem RN; El-Shikh WM
    Hepatogastroenterology; 2011; 58(107-108):949-54. PubMed ID: 21830422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acid-labile subunit of the ternary insulin-like growth factor complex in cirrhosis: relation to liver dysfunction.
    Møller S; Juul A; Becker U; Henriksen JH
    J Hepatol; 2000 Mar; 32(3):441-6. PubMed ID: 10735614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum insulinlike growth factor-1 and its binding protein-3 levels in children with cirrhosis waiting for a liver transplant.
    Dehghani SM; Karamifar H; Hamzavi SS; Haghighat M; Malek-Hosseini SA
    Exp Clin Transplant; 2012 Jun; 10(3):252-7. PubMed ID: 22631062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of growth hormone (GH), insulin-like growth factor (IGF)I, IGF binding proteins -1, -2, -3 and GH binding protein during progression of liver cirrhosis.
    Kratzsch J; Blum WF; Schenker E; Keller E
    Exp Clin Endocrinol Diabetes; 1995; 103(5):285-91. PubMed ID: 8536056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential role of insulin-like growth factor 1, insulin-like growth factor binding protein 3 and bone mineral density in patients with chronic hepatitis C virus in Cairo, Egypt.
    Raslan HM; Elhosary Y; Ezzat WM; Rasheed EA; Rasheed MA
    Trans R Soc Trop Med Hyg; 2010 Jun; 104(6):429-32. PubMed ID: 20189618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased IGF-I : IGFBP-3 ratio in patients with hepatocellular carcinoma.
    Mattera D; Capuano G; Colao A; Pivonello R; Manguso F; Puzziello A; D'Agostino L
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):699-706. PubMed ID: 14974910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential changes in insulin-like growth factor I (IGF-I) and IGF-binding proteins in children with end-stage liver disease before and after successful orthotopic liver transplantation.
    Holt RI; Jones JS; Stone NM; Baker AJ; Miell JP
    J Clin Endocrinol Metab; 1996 Jan; 81(1):160-8. PubMed ID: 8550746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ascites from patients with alcoholic liver cirrhosis contains higher IGF-I bioactivity than serum.
    Jeyaratnaganthan N; Grønbaek H; Holland-Fischer P; Espelund U; Chen JW; Flyvbjerg A; Vilstrup H; Frystyk J
    Clin Endocrinol (Oxf); 2010 May; 72(5):625-32. PubMed ID: 19769623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum concentrations of insulin-like growth factor-I (IGF-I) in patients with liver cirrhosis.
    Vyzantiadis T; Theodoridou S; Giouleme O; Harsoulis P; Evgenidis N; Vyzantiadis A
    Hepatogastroenterology; 2003; 50(51):814-6. PubMed ID: 12828091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating transforming growth factor beta(1) as an indicator of hepatic function impairment in liver cirrhosis.
    Flisiak R; Pytel-Krolczuk B; Prokopowicz D
    Cytokine; 2000 Jun; 12(6):677-81. PubMed ID: 10843744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in bronchoalveolar lavage fluid and serum of patients with lung cancer.
    Unsal E; Köksal D; Yurdakul AS; Atikcan S; Cinaz P
    Respir Med; 2005 May; 99(5):559-65. PubMed ID: 15823452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High insulin-like growth factor binding protein 1 levels in cirrhosis: link with insulin resistance.
    Shmueli E; Miell JP; Stewart M; Alberti KG; Record CO
    Hepatology; 1996 Jul; 24(1):127-33. PubMed ID: 8707251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.